Table 2.

Comparison of the characteristics of patients with/without 1-year recurrence

HBV, hepatitis B virus; HCV, hepatitis C virus; MELD, model for End-Stage Liver Disease; AFP, alpha-fetoprotein; PIVKA-II, protein induced by vitamin K absence II; MMF, mycophenolate mofetil.

^*Tacrolimus average exposure was defined as the area under the curve (AUC) of tacrolimus levels plotted against time courses until the time to recurrence or 1, 3, 6 month and one year after transplantation.

^†High tacrolimus exposure was defined as one year average tacrolimus exposure ≥7.5 ng/mL.